CANON MEDICAL ANNOUNCES RELEASE OF ALPHENIX / EVOLVE EDITION

Canon Medical announced that its new Angiography system, Alphenix / Evolve Edition is now available for commercial sale in Japan, Asian, African and European markets.

Alphenix / Evolve Edition delivers a range of industry-leading solutions for the Interventional Cardiology suite. Packaged under the αEvolve (alpha Evolve) technology umbrella of AI solutions, they provide real-time assistance that can instantaneously support key diagnostic and therapeutic decisions without interrupting the procedural flow.

αEvolve Imaging utilizes deep learning-based noise reduction and multi-frequency processing to enable sharp and clear fluoroscopic imaging, which can deliver two times higher contrast-to-noise ratio compared to conventional image processing, reducing the reliance on digital acquisition.

Dynamic Device Stabilizer (DDS) has been trained with deep learning to automatically detect balloon markers in real-time, magnifying and stabilizing the image on a separate screen to assist stent visualization and assessment during complex PCI procedures.

With the rise of SHD procedures such as left atrial appendage (LAA) closure, Echo Fusion taps into deep learning intelligence to automatically identify the echocardiography probe and efficiently fuse the fluoroscopic and echo image without additional operator input.

In addition, Alphenix / Evolve Edition offers a new level of intelligence and efficiency for the modern Interventional angiography suite through existing technologies like 12x12 inch flat panel detector (FPD) technology that provide complete procedural flexibility and Dose Tracking System (DTS) that provides real-time information on radiation dose.